Rapid Nutrition PLC (ALRPD.PA)
EUR 0.01
(-5.08%)
EUR 0.01
(-5.08%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 737.88 Thousand AUD | 53.61% |
| 2022 | 480.36 Thousand AUD | -86.39% |
| 2021 | 3.52 Million AUD | -2.52% |
| 2020 | 3.62 Million AUD | 0.0% |
| 2018 | 4.59 Million AUD | 39.58% |
| 2017 | 3.28 Million GBP | -12.67% |
| 2016 | 3.76 Million GBP | -17.22% |
| 2015 | 4.55 Million GBP | 47.69% |
| 2014 | 3.08 Million GBP | 5.84% |
| 2013 | 2.91 Million GBP | 38.88% |
| 2012 | 2.09 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q4 | 737.88 Thousand AUD | 0.0% |
| 2023 FY | 737.88 Thousand AUD | 53.61% |
| 2023 Q2 | 463.73 Thousand AUD | 0.0% |
| 2023 Q1 | 463.73 Thousand AUD | -3.46% |
| 2023 Q3 | 737.88 Thousand AUD | 59.12% |
| 2022 FY | 480.36 Thousand AUD | -86.39% |
| 2022 Q4 | 480.36 Thousand AUD | 0.0% |
| 2022 Q3 | 480.36 Thousand AUD | -74.19% |
| 2022 Q2 | 1.86 Million AUD | 3.21% |
| 2022 Q1 | 1.8 Million AUD | -48.9% |
| 2021 Q1 | 2.86 Million AUD | 0.0% |
| 2021 Q3 | 3.52 Million AUD | 16.71% |
| 2021 Q4 | 3.52 Million AUD | 0.0% |
| 2021 Q2 | 3.02 Million AUD | 5.48% |
| 2021 FY | 3.52 Million AUD | -2.52% |
| 2020 FY | 3.62 Million AUD | 0.0% |
| 2019 Q1 | 3.95 Million AUD | 22.94% |
| 2019 Q4 | 4.58 Million AUD | 0.0% |
| 2019 Q3 | 4.58 Million AUD | -0.09% |
| 2019 Q2 | 4.59 Million AUD | 16.03% |
| 2018 FY | 4.59 Million AUD | 39.58% |
| 2018 Q4 | 3.21 Million GBP | 0.0% |
| 2018 Q3 | 3.21 Million AUD | -2.15% |
| 2018 Q1 | 3.37 Million AUD | -31.92% |
| 2018 Q2 | 3.28 Million GBP | -2.55% |
| 2017 FY | 3.28 Million GBP | -12.67% |
| 2017 Q3 | 4.88 Million AUD | 29.79% |
| 2017 Q1 | 3.64 Million AUD | -9.28% |
| 2017 Q2 | 3.76 Million GBP | 3.23% |
| 2017 Q4 | 4.95 Million GBP | 1.42% |
| 2016 Q4 | 4.02 Million GBP | 38.85% |
| 2016 Q2 | 4.55 Million GBP | 33.91% |
| 2016 Q1 | 3.39 Million AUD | 7.65% |
| 2016 FY | 3.76 Million GBP | -17.22% |
| 2016 Q3 | 2.89 Million AUD | -36.34% |
| 2015 Q4 | 3.15 Million GBP | 0.0% |
| 2015 Q3 | 3.15 Million AUD | 2.46% |
| 2015 Q2 | 3.08 Million GBP | 0.0% |
| 2015 Q1 | 3.08 Million AUD | 35.71% |
| 2015 FY | 4.55 Million GBP | 47.69% |
| 2014 Q3 | 2.27 Million AUD | -22.01% |
| 2014 Q2 | 2.91 Million AUD | 0.0% |
| 2014 Q4 | 2.27 Million GBP | 0.0% |
| 2014 FY | 3.08 Million GBP | 5.84% |
| 2013 Q2 | 2.09 Million AUD | 0.0% |
| 2013 FY | 2.91 Million GBP | 38.88% |
| 2012 FY | 2.09 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AB Science S.A. | 46.5 Million EUR | 98.413% |
| Boiron SA | 198.7 Million EUR | 99.629% |
| Ipsen S.A. | 2.49 Billion EUR | 99.97% |
| Malin Corporation plc | 7.1 Million EUR | 89.607% |
| Vetoquinol SA | 165.12 Million EUR | 99.553% |